middle.news
Entropy Neurodynamics Doses First Patient in Groundbreaking IV Psilocin BED Trial
9:19am on Tuesday 2nd of December, 2025 AEDT
•
Biotechnology
Read Story
Entropy Neurodynamics Doses First Patient in Groundbreaking IV Psilocin BED Trial
9:19am on Tuesday 2nd of December, 2025 AEDT
Key Points
First patient safely dosed with TRP-8803 in Binge Eating Disorder trial
Trial involves 12 patients across two dosing cohorts with supportive therapy
IV infusion allows precise control over psychedelic experience duration and intensity
Top-line results expected in the first quarter of 2026
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Entropy Neurodynamics (ASX:ENP)
OPEN ARTICLE